腰椎管狭窄症的诊断与治疗:综述
该综述指出腰椎管狭窄症是老年人腰腿痛的常见致残病因,全球约1.03亿人患病,美国成人临床综合征患病率约11%且随年龄增长。诊断通常基于腰部后伸诱发、屈曲缓解的腰腿痛病史,并由CT或MRI等横断面影像确认。非手术治疗包括减少站立或行走时间的活动调整、口服非甾体抗炎药(NSAIDs)等镇痛药和物理治疗;硬膜外类固醇注射的长期获益未获证实。在严格选择的保守治疗无改善的患者中,手术似乎有效;减压椎板切除术在随机试验中改善症状优于非手术(差异7.8分,95%CI 0.8-14.9,低于最小临床重要差异10-12.8),而合并脊椎滑脱者是否加做融合仍不明确。
要点
- 诊断通常基于腰部后伸诱发、屈曲缓解的腰腿痛病史,并由CT或MRI等横断面影像确认。
- 美国成人腰椎管狭窄症临床综合征患病率约11%,随年龄增长;全球约1.03亿人患病。
- 一线治疗为活动调整(减少站立或行走时间)、NSAIDs等口服镇痛药和物理治疗。
- 硬膜外类固醇注射治疗腰椎管狭窄症的长期获益未获证实。
- 随机试验中减压椎板切除术改善症状优于非手术(Oswestry残疾指数差异7.8分,95%CI 0.8-14.9;最小临床重要差异10-12.8)。
适用人群与场景
- 老年人腰腿痛人群;美国成人临床综合征患病率约11%,随年龄增长。
- 全球约1.03亿人患病;美国每年约60万例手术用于腰椎管狭窄症。
- 大多数患者接受非手术治疗。
诊断标准与关键阈值
- 诊断通常基于腰部后伸诱发的腰腿痛病史、腰部屈曲缓解,并由CT或MRI等横断面影像确认。
处置流程与药物剂量
- 非手术治疗包括活动调整(如减少站立或行走时间)、口服NSAIDs等减轻疼痛的药物和物理治疗。
- 硬膜外类固醇注射的长期获益未获证实。
- 经选择的保守治疗无改善、持续疼痛和活动受限的患者可考虑减压手术。
- 合并脊椎滑脱者是否加做腰椎融合的精确指征仍不明确。
研究设计与关键结果
- 综述指出腰椎管狭窄症全球约1.03亿人患病,美国成人临床综合征患病率约11%且随年龄增长,美国每年约60万例手术。
- 非手术随访至3年的患者系列中,约三分之一报告改善,约50%报告症状无变化,约10%-20%报告背痛、腿痛和行走更差。
- 随机试验94例有症状和影像学退行性腰椎管狭窄症患者中,减压椎板切除术改善症状优于非手术(Oswestry残疾指数差异7.8分,95%CI 0.8-14.9;最小临床重要差异10-12.8,评分范围0-100)。
- 合并脊椎滑脱者中,1项试验显示腰椎融合增加症状缓解(36项简短健康调查躯体维度评分差异5.7分,95%CI 0.1-11.3,评分范围0-100),但另2项试验显示两种治疗无重要差异或单纯腰椎减压不劣于减压加融合(最小临床重要差异2-4.9分)。
- 非劣效试验中,单纯腰椎减压组71.4% vs 减压加融合组72.9%达到Oswestry残疾指数评分降低30%或以上,符合预设非劣效假设。
- 融合与更高并发症风险相关,如失血、感染、住院时间更长和费用更高。
证据类型、等级与局限
- 综述;证据来自随机试验和患者系列。
- 局限:原文未报告局限性。
对床旁实践的改变
- 一线治疗为活动调整、镇痛和物理治疗;硬膜外类固醇注射长期获益未确立,不应作为追求长期获益的常规手段。
- 经选择的持续疼痛和活动受限患者可考虑减压手术;合并脊椎滑脱者加做融合的精确指征仍不明确,且融合与更高并发症风险相关(失血、感染、住院时间更长、费用更高)。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Lumbar spinal stenosis is a prevalent and disabling cause of low back and leg pain in older persons, affecting an estimated 103 million persons worldwide. Most are treated nonoperatively. Approximately 600 000 surgical procedures are performed in the US each year for lumbar spinal stenosis.
OBSERVATIONS: The prevalence of the clinical syndrome of lumbar spinal stenosis in US adults is approximately 11% and increases with age. The diagnosis can generally be made based on a clinical history of back and lower extremity pain that is provoked by lumbar extension, relieved by lumbar flexion, and confirmed with cross-sectional imaging, such as computed tomography or magnetic resonance imaging (MRI). Nonoperative treatment includes activity modification such as reducing periods of standing or walking, oral medications to diminish pain such as nonsteroidal anti-inflammatory drugs (NSAIDs), and physical therapy. In a series of patients with lumbar spinal stenosis followed up for up to 3 years without operative intervention, approximately one-third of patients reported improvement, approximately 50% reported no change in symptoms, and approximately 10% to 20% of patients reported that their back pain, leg pain, and walking were worse. Long-term benefits of epidural steroid injections for lumbar spinal stenosis have not been demonstrated. Surgery appears effective in carefully selected patients with back, buttock, and lower extremity pain who do not improve with conservative management. For example, in a randomized trial of 94 participants with symptomatic and radiographic degenerative lumbar spinal stenosis, decompressive laminectomy improved symptoms more than nonoperative therapy (difference, 7.8 points; 95% CI, 0.8-14.9; minimum clinically important difference, 10-12.8) on the Oswestry Disability Index (score range, 0-100). Among persons with lumbar spinal stenosis and concomitant spondylolisthesis, lumbar fusion increased symptom resolution in 1 trial (difference, 5.7 points; 95% CI, 0.1 to 11.3) on the 36-Item Short Form Health Survey physical dimension score (range, 0-100), but 2 other trials showed either no important differences between the 2 therapies or noninferiority of lumbar decompression alone compared with lumbar decompression plus spinal fusion (MCID, 2-4.9 points). In a noninferiority trial, 71.4% treated with lumbar decompression alone vs 72.9% of those receiving decompression plus fusion achieved a 30% or more reduction in Oswestry Disability Index score, consistent with the prespecified noninferiority hypothesis. Fusion is associated with greater risk of complications such as blood loss, infection, longer hospital stays, and higher costs. Thus, the precise indications for concomitant lumbar fusion in persons with lumbar spinal stenosis and spondylolisthesis remain unclear.
CONCLUSIONS AND RELEVANCE: Lumbar spinal stenosis affects approximately 103 million people worldwide and 11% of older adults in the US. First-line therapy is activity modification, analgesia, and physical therapy. Long-term benefits from epidural steroid injections have not been established. Selected patients with continued pain and activity limitation may be candidates for decompressive surgery.
参考来源
- Katz JN, Zimmerman ZE, Mass H, et al. Diagnosis and Management of Lumbar Spinal Stenosis: A Review. JAMA. 2022. PMID: 35503342. doi:10.1001/jama.2022.5921
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。